Ocean View, DE -- (SBWIRE) -- 03/31/2020 -- Neuroendoscopy market is expected to exceed USD 250 million by 2025. The advantages associated with neuroendoscopic devices will drive the market growth over analysis period.

Some major findings of the neuroendoscopy market report include:

Recent advancements and innovations in minimally invasive technologies has resulted in increase in number of minimally invasive neurosurgeries across the globe

Technological innovations and developments in manufacturing of novel neuroendoscopy devices will boost the market growth in near future

Request sample copy of this report @ https://www.decresearch.com/request-sample/detail/4039
Increasing use of minimally invasive instruments such as neuroendoscopes has allowed surgeons to reduce morbidity during the surgical procedures by reducing the need for large surgical incisions

Growing geriatric population is one of the primary factors driving the neuroendoscopy market growth

Increasing number of brain tumor cases worldwide will result in augmenting the demand and adoption rate of neuroendoscopy surgical procedures, thereby propelling the neuroendoscopy market growth. Several risk factors such as exposure to radiation and family history of brain tumors has surged the risk of brain tumor across the globe. Brain tumor is an abnormal growth of tissue specifically in central spine and brain that can disrupt the normal brain function. Various types of tumors such as acoustic neuroma, astrocytoma, glioblastoma, meningioma, craniopharyngioma and glioma among others will further increase the number of neurosurgery procedures. Furthermore, rapid increase in brain tumor cases in Asian countries such as India, Japan, China and Singapore among others will pave market growth opportunities in the region. Hence, rising brain and central nervous system cancer cases will have a significantly positive impact on the industry growth.

The product segment is bifurcated into rigid and flexible neuroendoscopes. Rigid neuroendoscopes segment was valued at around USD 120 million in 2018 and is projected to witness lucrative growth opportunities over the analysis timeline. Rigid endoscopes are instruments that are extensively used during endoscopic procedures to investigate the internal body organs with the help of a tubular telescope. Moreover, increasing application of rigid neuroendoscopes in intraventricular neuroendoscopy will foster the segmental growth.

Make Inquiry about this report @ https://www.decresearch.com/inquiry-before-buying/4039

Application segment covers transnasal neuroendoscopy, intraventricular neuroendoscopy and transcranial neuroendoscopy. Transnasal neuroendoscopy segment is anticipated to witness around 25.1% revenue share during forthcoming years. Transnasal neuroendoscopy is indicated for use in endoscope-assisted micro-neurosurgery and pure neuroendoscopy. It is widely used for direct visualization, diagnosis and therapeutic procedures including removal of cysts and tumors. Additionally, improvements in surgical instrumentation further allows neurosurgeons to treat more complex surgeries through customized less invasive approaches. Therefore, rising applications of transnasal neuroendoscopy surgical procedure will accelerate the industry progression.

Usability segment is classified based on reusable neuroendoscopes and disposable neuroendoscopes. Disposable neuroendoscopes segment will exhibit 5.5% CAGR during the analysis period owing to increasing demand for disposable neuroendoscopes over the reusable ones. Disposable neuroendoscopes are sterile and possess lower risk of patient infection that enhances the segmental demand. Moreover, development of temporary disposable neuroendoscopes for brain and central nervous system surgeries will augment the neuroendoscopy business growth.

Patient segment is further divided into adult and pediatric. The pediatric segment was valued at around USD 25 million in 2018 and is estimated to witness substantial growth during analysis period. Medulloblastomas, astrocytomas, ependymomas and brainstem gliomas are the most common tumor types occurring among children that boosts the neuroendoscopy industry growth. Additionally, presence of qualified pediatric neurosurgeons in developed countries to efficiently diagnose children's health proves beneficial for the business growth.

End-use segment covers hospitals, ambulatory surgical centers (ASCs), diagnostic centers and others. ASCs are anticipated to witness over 20% revenue share in 2018. ASCs offer several benefits as compared to hospitals and diagnostic centers such as shorter hospital stay, well-equipped devices and low risk of developing hospital acquired infection. Also, presence of skilled healthcare professionals coupled with rising number of neuro surgeries will fuel the segmental growth.

Asia Pacific neuroendoscopy market accounted for around USD 30 million in 2018. The rising awareness among individuals regarding the neuroendoscopy procedures to effectively diagnose patient health will enhance the business growth. Also, growing healthcare expenditure in developing countries of Asia Pacific will promote the regional growth.

Some of the notable industry players operating in neuroendoscopy market are Clarus Medical, B. Braun, KARL STORZ, adeor medical, Ackermann Instrumente, Schindler endoskopie technologie, Tonglu WANHE, Machida Endoscope and HAWK. The industry players undertake different organic and inorganic growth strategies to maintain the market competition. For instance, KARL STORZ maintains its financial stability by developing superior quality neuroendoscopy devices. The firm has established secured presence in neuroendoscopy industry, thus further enhancing the product range of the firm.